Your browser doesn't support javascript.
loading
Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa collected in central and northern Europe (Belgium, Norway, Sweden, Switzerland)-SMART 2017-21.
Karlowsky, James A; Lob, Sibylle H; Hawser, Stephen P; Kothari, Nimmi; Siddiqui, Fakhar; Alekseeva, Irina; DeRyke, C Andrew; Young, Katherine; Motyl, Mary R; Sahm, Daniel F.
Afiliação
  • Karlowsky JA; IHMA, Schaumburg, IL 60173, USA.
  • Lob SH; Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Hawser SP; IHMA, Schaumburg, IL 60173, USA.
  • Kothari N; IHMA, Monthey, Switzerland.
  • Siddiqui F; IHMA, Monthey, Switzerland.
  • Alekseeva I; Merck & Co., Inc., Rahway, NJ, USA.
  • DeRyke CA; MSD, Dubai, United Arab Emirates.
  • Young K; Merck & Co., Inc., Rahway, NJ, USA.
  • Motyl MR; Merck & Co., Inc., Rahway, NJ, USA.
  • Sahm DF; Merck & Co., Inc., Rahway, NJ, USA.
JAC Antimicrob Resist ; 5(4): dlad098, 2023 Aug.
Article em En | MEDLINE | ID: mdl-37577157

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article